UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13...
OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response 2.50 SEC FILE NUMBER CUSIP NUMBER UNITED...
Xcorporeal, Inc. (AMEX:XCR) announced today the XCR-6 Dialysis Platform for self-directed kidney hemodialysis. The XCR-6 will be...
Xcorporeal, Inc. (AMEX:XCR) announced today that Victor Gura M.D., the Company?s Chief Scientific and Medical Officer, will...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Xcorporeal, Inc. (AMEX:XCR) announced today that Kelly J. McCrann has been appointed Chairman and Chief Executive Officer. Mr...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________...
Xcorporeal, Inc. (AMEX:XCR) announced today that Dan Goldberger of Xcorporeal will be presenting at The William Blair 2008 Annual...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-KSB/A Amendment No. 2 x ANNUAL REPORT UNDER...
FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.